{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:34:22Z","timestamp":1777937662514,"version":"3.51.4"},"reference-count":5,"publisher":"SAGE Publications","issue":"13","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1177\/13524585221125370","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T08:48:03Z","timestamp":1664354883000},"page":"2146-2146","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cladribine-induced liver injury: Implications for practice"],"prefix":"10.1177","volume":"28","author":[{"given":"Wallace J","family":"Brownlee","sequence":"first","affiliation":[{"name":"Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"bibr1-13524585221125370","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211012227"},{"key":"bibr2-13524585221125370","unstructured":"European Medicines Agency. Mavenclad (cladribine) \u2013 Risk of serious liver injury and new recommendations about liver function monitoring, https:\/\/www.ema.europa.eu\/en\/medicines\/dhpc\/mavenclad-cladribine-risk-serious-liver-injury-new-recommendations-about-liver-function-monitoring"},{"key":"bibr3-13524585221125370","unstructured":"Medicines and Healthcare products Regulatory Agency. Cladribine (Mavenclad): New advice to minimise risk of serious liver injury, https:\/\/www.gov.uk\/drug-safety-update\/cladribine-mavenclad-new-advice-to-minimise-risk-of-serious-liver-injury"},{"key":"bibr4-13524585221125370","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221125360"},{"key":"bibr5-13524585221125370","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.968"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585221125370","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585221125370","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585221125370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:10:33Z","timestamp":1777695033000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585221125370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":5,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1177\/13524585221125370"],"URL":"https:\/\/doi.org\/10.1177\/13524585221125370","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]}}}